Scientists have engineered adeno-associated viruses (AAVs) to package and deliver gene therapies to cells in the body. But the field has struggled to develop AAVs that can efficiently target different cell types and organs such as the brain, driving scientists to look for better ways of developing new viral vectors.
Click here for original story, Researchers reprogram gene therapy viral vectors to bind specific protein targets
Source: Phys.org